EUVIMEDFaigh amach EUVIMED
Crossref

Will preoperative trials change future clinical practice?

Elgene Lim, Eric P Winer

Clinical Investigation · 2011

DOI: 10.4155/cli.10.3 ↗

At a glance

Journal article in Clinical Investigation, 2011. Written by Elgene Lim and 1 co-authors. Cited 1 times so far (Crossref); 96 references.

AchoimreSonraí leabharliostaCiteRelated studies

Abstract (original language)

Preoperative systemic therapy (PST) has emerged from an infrequently used approach in the management of patients with breast cancer to one with an established role in both inoperable and operable breast cancer. In particular, it now has an established role in drug development and biomarker discovery programs. In this era of molecular-based therapies, the unique resource of paired pre- and post-treatment tissue in PST trials represents a powerful research tool for the in vivo study of biologic mechanisms of systemic therapy. It is possible to examine downregulation of signaling pathways that are known to be activated, and off-target effects through the identification of pathways not previously known to be activated. In addition, correlative studies may identify predictive biomarkers of response and resistance, which has the potential to inform the design of larger and more expensive adjuvant trials. The aims of this article are to review key developments in PST trials, particularly in specific breast cance...

Cite

APA

Lim, E., & Winer, E. P. (2011). Will preoperative trials change future clinical practice?. Clinical Investigation. https://doi.org/10.4155/cli.10.3

Vancouver

Lim E, Winer EP. Will preoperative trials change future clinical practice?. Clinical Investigation. 2011. doi:10.4155/cli.10.3

BibTeX
@article{Lim2011,
  author = {Lim, Elgene and Winer, Eric P},
  title = {Will preoperative trials change future clinical practice?},
  journal = {Clinical Investigation},
  year = {2011},
  doi = {10.4155/cli.10.3}
}
Start for free →